Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Ageas SA/NV    AGS   BE0974264930

AGEAS SA/NV

(AGS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Hedge funds make pandemic bet on insurance

10/07/2020 | 09:30am EST
FILE PHOTO: Skyscrapers in The City of London financial district are seen during sunrise in London

LONDON (Reuters) - Five years after London-based hedge fund Toscafund ditched the shares it held in insurance companies, the $3.5 billion firm and its peers are flocking back, drawn by sharp premium increases which are lifting the sector's post-coronavirus prospects.

Insurers faced a surge in claims spanning trade credit to event cancellations as a result of the pandemic. Some have pulled out of unprofitable lines of business but for those who remain, the crisis has led to a steep rise in premiums, or a so-called "hardening" of the market, typical after a period of heavy losses.


Commercial insurance rateshttps://tmsnrt.rs/3nuB046 rose 19% year-on-year in the April-June quarter, says Marsh, the world's largest insurance broker, the most since the firm started compiling data in 2012.

(Graphic: Global commercial insurance premiums (% change) https://graphics.reuters.com/HEALTH-CORONVIRUS/INSURANCE/xegpbjdeypq/chart.png)

Insurance was a successful part of Toscafund's portfolios after 2012 as companies shelved expansion plans and started returning capital to shareholders, but that trade had faded by 2015, said Nigel Gliksten, a partner at the fund.

Now though, the sector looks more attractive.

"We've gone back into insurance this year. We've got (about) 15% weighting in the sector from stocks that we think will benefit from a significant hardening," Gliksten said, adding that the pandemic had changed pricing levels "meaningfully".

Share prices have yet to reflect a shift in prospects. A European insurance sub-index is down 25% this year, its worst performance since 2009. Lancashire and RenaissanceRe, two major holdings in Toscafund's long-short equity fund, still trade at end-May lows, with year-to-date losses of more than 10%.

Funds such as Copper Street Capital are also betting that will change. Its founding partner and chief investment officer, Jerry Del Missier told Reuters he had recently hired an insurance analyst to start at the end of the year.

The recent shocks would throw up "challenges and opportunities" in insurance, he predicted.

NEW PRODUCTS FOR THE NEW NORMAL

Investors reckon that in a world where virus outbreaks and climate disasters may be the new normal, innovative new insurance products such as those providing relief during future lockdowns or when staff sickness hinders business, will prove lucrative.

Even while share prices remain subdued, insurers' debt sales for the most part have been oversubscribed this year, thanks to strong credit quality, typically in the single-A category.

Alex Eventon, portfolio manager at London-based Resco Asset Management said he also saw higher-yielding restricted tier 1 (RT1) subordinated debt as "an interesting asset class for macro guys like ourselves", though he declined to provide details.

Issuers of RT1 debt this year include Ageas, Legal & General and Phoenix.

Meanwhile, hedge funds are also said by insurance industry sources to be piling into catastrophe bonds -- securities issued by insurers, sovereigns and others to insure against climate risk or natural disasters.

While bondholders don't get paid in the event of a natural catastrophe, hedge funds are attracted to the high-yielding debt, according to one insurance official whose firm issued such a bond.

Global catastrophe bond issuance hit $6.5 billion in the first half of 2020, surpassing 2019 full-year issuance by 20%, according to insurance broker Aon.

RISKS TURNING

Hedge fund managers say insurance markets started to turn in late spring but it's only now that COVID-19 risks are clearing.

U.S. courts have begun ruling on business interruption cases -- brought by those whose insurers declined to compensate for pandemic disruption -- and a British test case, though headed for appeal courts, could provide more clarity.

"Maybe people are feeling more comfortable now with those risks, while also getting the pricing," one hedge fund manager said.

(Reporting by Maiya Keidan and Carolyn Cohn, additional reporting by Abhinav Ramnarayan; editing by Sujata Rao, Kirsten Donovan)

By Maiya Keidan and Carolyn Cohn


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
AGEAS SA/NV 0.88% 42.59 Delayed Quote.-19.86%
LANCASHIRE HOLDINGS -2.82% 741.5 Delayed Quote.-0.52%
LEGAL & GENERAL PLC -0.53% 264.4 Delayed Quote.-12.28%
All news about AGEAS SA/NV
11/25AGEAS / : EU insurance watchdog under pressure to scrap blanket dividend ban
RE
11/24AGEAS AND BLACKROCK : Transparency notification
AQ
11/13GLOBAL MARKETS LIVE: Washington vs Beijing, Farfetch beats expectations…
11/13AGEAS / : reports on third quarter results 2020
AQ
11/13AGEAS SA/NV : Press Release
CO
11/13AGEAS SA/NV : 3rd quarter results
CO
11/10AGEAS SA/NV : quaterly earnings release
11/10AGEAS SA/NV : Admission of new securities
CO
11/09AGEAS AND GOLDMAN SACHS : Transparency notification
AQ
11/09AGEAS SA/NV : Admission of new securities
CO
More news
Financials
Sales 2020 7 620 M 9 234 M 9 234 M
Net income 2020 1 169 M 1 417 M 1 417 M
Net Debt 2020 1 402 M 1 699 M 1 699 M
P/E ratio 2020 6,78x
Yield 2020 6,21%
Capitalization 7 965 M 9 623 M 9 651 M
EV / Sales 2020 1,23x
EV / Sales 2021 1,09x
Nbr of Employees 10 741
Free-Float 90,2%
Chart AGEAS SA/NV
Duration : Period :
ageas SA/NV Technical Analysis Chart | AGS | BE0974264930 | MarketScreener
Technical analysis trends AGEAS SA/NV
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 44,70 €
Last Close Price 42,59 €
Spread / Highest target 29,1%
Spread / Average Target 4,96%
Spread / Lowest Target -22,5%
EPS Revisions
Managers
NameTitle
Hans de Cuyper Chief Executive Officer
Bart Karel de Smet Chairman
Christophe Boizard Chief Financial Officer & Executive Director
Guy Jacques Marie de Selliers de Moranville Vice Chairman
Lionel Perl Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AGEAS SA/NV-19.86%9 517
ALLIANZ SE-8.43%99 242
CHUBB LIMITED-1.95%68 885
ZURICH INSURANCE GROUP LTD-6.02%61 680
MARSH & MCLENNAN COMPANIES2.90%59 007
BAJAJ FINSERV-6.89%18 933